Implantable Cardiac Monitors Market by Indication (Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls) and End User (Hospitals, Cardiac Centers & Clinics and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2017-2023
An implantable cardiac monitor is a small monitoring device, which is used to record the electrical activity of the heart. The device is embedded under the skin of the patient’s chest from where the heart’s electrical activity is recorded.
The device can be activated either by adjusting the heart rate according to the range set by the physician or can be externally triggered with the push of a button. These recordings are used by the physicians to analyze and identify an abnormal heart rhythm.
The device is used to monitor patients who are at risk for myocardial infraction and atrial fibrillation. The global implantable cardiac monitors market was valued at $410.4 million in 2016, and is expected to reach at $678.3 million by 2023, registering a CAGR of 7.4% from 2017 to 2023.
A major factor that drives implantable cardiac monitors market is their longevity. In addition, the implantable nature does not require any admission to the hospital, and the patient can be monitored while performing the daily activities.
Moreover, rise in incidence of patients suffering from atrial fibrillation, increase in prevalence of myocardial infraction, and unhealthy lifestyle are some other factors that boost the market growth. However, availability of alternative mode of treatment and inflated cost of device hamper the market growth.
Conversely, increase in awareness among patients these devices and treatment options for management of cardiac disorders provide lucrative market growth opportunities.
The global implantable cardiac monitors market is segmented based on indication, end user, and region. On the basis of indication, the market is divided into cardiac arrhythmias, atrial fibrillation, and epilepsy & unexplained falls.
By end user, it is classified into hospitals, cardiac centers & clinics and ambulatory surgical centers (ASCs).
Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in 2016, and is expected to maintain its dominance throughout the forecast period.
This is attributed to increase in development of sophisticated cardiac devices and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, due to the improvements in healthcare facilities, increase in disposable income, and improvement in economic conditions.
KEY BENEFITS FOR STAKEHOLDERS The study provides an in-depth analysis of the global implantable cardiac monitors market, with current trends and future estimations to elucidate the imminent investment pockets. Comprehensive analysis of factors that drive and restrict the market growth is provided. Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable stakeholders to capitalize on the prevailing market opportunities. Extensive analysis of the key segments of the industry, which helps understand the type of products and technologies used globally is included. Key market players and their strategies are provided to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Indication Cardiac Arrhythmias Atrial Fibrillation Epilepsy & Unexplained Falls
By End User Hospitals Cardiac Centers & Clinics Ambulatory Surgical Centers (ASCs)
By Region North America U.S. Canada Mexico Europe UK France Germany Italy Spain Switzerland Rest of Europe Asia-Pacific Japan China India Australia Malaysia New Zealand Rest of Asia-Pacific LAMEA Brazil South Africa Egypt Rest of LAMEA
KEY PLAYERS PROFILED Abbott Laboratories Biotronik SE & Co. KG Boston Scientific Corporation Edwards Lifescience Corporation General Electric Company Koninklijke Philips N.V. LivaNova PLC Medtronic plc Nihon Kohden Corporation Phoenix Heart Center
The other players in the value chain include (profiles not included in the report) Abiomed, Inc. Berlin Heart GmbH Jarvik Heart, Inc. ReliantHeart Inc. Schiller AG Astellas Pharma, Inc. Sigma-Aldrich Corporation Agilent Technologies, Inc. Basilea Pharmaceutical Ltd.
Our reports have been used by over 10K customers, including:
Electrocardiogram Equipment Market Research Report by Product (Holter Monitors, Resting ECG Systems, and Stress ECG Systems), by Lead Type (12-Lead Type, 3-6 Lead Type, and Single-lead Type), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing...
Mobile Cardiac Telemetry Devices Market Research Report by Technology (Lead-based Technology and Patch-based Technology), by End-User (Ambulatory Surgical Centers, Clinics, and Hospitals) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across...
Diagnostic Electrocardiograph Market Research Report by Product (Holter Monitor System, Rest System, and Stress System), by Lead Type (12-lead, 3-lead, 5-lead, 6-lead, and Single-lead), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast...
Implantable Cardiac Monitor Market Research Report by End User (Ambulatory Surgical Centers, Cardiac Centers & Clinics, and Hospitals) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD....
Cardiac Holter Monitor Market Research Report by Component (Holter Analysis System, Holter Software, Wired Holter, and Wireless Holter), by Product (-Channel, 12-Channel, 2-Channel, and 3-Channel), by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market...
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Research Report by Cardiac Monitoring Devices (Cardiac Output Monitoring Devices, Ecg Devices, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry Devices), by Cardiac Rhythm Management Devices (Defibrillators and Pacemakers), by End User - Global Forecast...
The patient monitoring devices market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period. Growth of the market is mainly attributed to the technological advancements; increasing incidences of infectious diseases, and growing public and private investments, funding, and...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Holter Monitors Market Report The holter monitors market by revenue is expected to grow at a CAGR of over 8% during the period 2020–2025. The global Holter monitors market is one of the fastest-growing segments of the ambulatory cardiac...
137 pages •
By Global Industry Analysts
• Sep 2020
Global Cardiac Monitoring Devices Market to Reach $9.1 Billion by 2027 Amid the COVID-19 crisis, the global market for Cardiac Monitoring Devices estimated at US$5.8 Billion in the year 2020, is projected to reach a revised size of US$9.1 Billion by 2027, growing at a CAGR of 6.6% over the analysis period 2020-2027. Electrocardiogram...
ECG Monitoring Equipment - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “ECG Monitoring Equipment - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the ECG Monitoring Equipment pipeline products with comparative analysis of the...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.